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Abstract. The bone marrow is composed of the non-adherent hematopoietic and adherent stromal cell 
compartments. This adherent bone marrow stromal cell fraction contains pluripotent mesenchymal stem cells 
and differentiated mesenchymal bone marrow stromal cells. In vivo the mesenchymal stem cells self-renew by 
proliferation while maintaining their stem-cell phenotype and give rise to the differentiated stromal cells which 
belong to different lineages. This experimental study demonstrate that mesenchymal stem cells from dog bone 
marrow had the in vitro capability to differentiate in osteogenic and chondrogenic lineages after culture in proper 





The bone marrow (BM) consists of a complex and heterogeneous mixture of different 
cell types. It includes the hematopoietic system and the BM stroma which interact in a 
reciprocal fashion through inter-cellular contact and secretion of cytokines or growth factors. 
The hematopoietic system contains hematopoietic stem and progenitor cells and BM stroma 
corresponds to the adherent cell layer that support hematopoiesis and that differentiate in 
different cells lineage (5) (fig. 1).  
 
Fig.1. MSCs differentiation into multiple mesenchymal lineages including osteogenic, chondrogenic, 
tendonogenic, adipogenic and myogenic lineages those contribute to the formation of mesenchymal tissues 
(bone, cartilage, muscle, ligament, tendon, marrow stroma, fat and connective tissue) 
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These cells obtained from the adherent BM fraction, mesenchymal stem cells (MSCs), 
because of their differentiating properties, could serve to develop in vitro replacement cells 
and tissues for congenital or degenerative disorders, as well as for traumatic bone lesions that 
exceed critical size defects and for gene therapy. 
In this experimental study we try dog’s MSCs cultivation following a standard 
protocol used for human bone marrow stromal cells and in vitro differentiation of these cells 
in two lineages: osteogenic and chondrogenic. The resulting cells was used for loading 
scaffolds consisting in collagen and collagen with hydroxyapatite, components that are 
normally find in cartilage and bone structure.  
 
MATERIAL AND METHODS 
 
This study was performed on six medium-sized healthy crossbreed dogs, with ages 
ranging from 2 to 3 years. Each dog was clinically and radiographically examined before bone 
marrow sampling. The bone marrow was obtained from the proximal humeral epiphysis. 
From each dog a quantity of 4 ml of bone marrow aspirate was taken onto 1 ml of 
anticoagulant (Heparine) (fig. 2). 
 
 
Fig.2. Bone marrow sampling from the proximal humeral epiphysis 
 
The samples were processed on the same day when were obtained. In the lab, the 
samples were transferred into sterile tubes and then PBS was added. After bone marrow 
stromal cells sedimentation, the supernatant (PBS, serum, erythrocytes, and fat substances) 
was discarded and onto the remaining sediment (cells) being added standard culture media. 
The cells were placed into cell culture plates approximately 1 million cells/cm2.  
Standard procedure in MSCs cultivation and differentiation:  
- day 0 – beginning of the cultivation process: cell culture plates were incubated at 
37°C. 
- day 2-9 – oxygenation and culture media replacement; 
- day 10-21 – in the moment of reaching the semiconfluence point (60-80% cells are 
closely attached to each other) was made tripsinization and, after that, passage I; 
- day 21-42 – incubation, periodically replacement of culture media, tripsinization and 
passage II; 
- day 42- 63 – incubation, periodically replacement of culture media, tripsinization and 
passage onto differentiation media. 
In this process were used: standard culture media (DMEM =FCS10% + 2µg FGF); 
osteoblastic differentiation media (Dexamethasone); chondroblastic differentiation media 
(TGF β1). All the passage was preceded by tripsinization for detachment of the cells from the 
plastic surface of the culture plates:  warm trypsine was added (7.5 ml/large plate) and contact 
maintained for maximum 2 minutes. The loose cells were passed onto the cold FCS media. 
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The mixture was centrifuged at 1,500 rpm, for 10 minutes, and then passed again onto the ice. 
The supernatant was discarded and the cells were suspensioned with PBS. From the cells 
suspension, 1 ml was taken and Tripan stained for microscopically monitoring and counting. 
The cells are placed again onto plates in concentrations of 3,000-5,000 cells/cm2. 
The differentiation was carried out in vitro, on well plates, and directly on scaffolds 
(collagen and hydroxyapatite matrixes and collagen membranes) (fig. 3, 4, 5 and 6); interval 





For verification of osteogenic induction was used von Kossa stain after 15 days from 
the cells transfer in osteoblastic differentiation media.  For an osteoblastic scaffold was used a 
number of 4-6 million cells, meaning around 50,000 cells/cm2 and for a chondroblastic 
scaffolds was used a number of 1-3 millions cells/scaffold, meaning around 20,000 cells/cm2.  
 
RESULTS AND DISCUSSIONS  
 
Bone marrow stromal cells from the samples had a density approximately 2.5 x 104 
nucleate cells.  The cellularity index was between 25% and 75% (normocellularity), superior 
to data reported for femoral condyles (4).  
After one week, the majority of MSCs isolated from the dog’s bone marrow had a 




Fig.3.  Collagen and hydroxyapatite matrix 
for osteoblasts culture  
Fig.4. Collagen membrane for 
chondroblasts culture  
 
 
Fig.5.  Collagen and hydroxyapatite matrix 
in culture media containing osteoblasts 
Fig.6. Collagen membrane in culture 




Fig. 7. MSCs morphology in one week 
culture. Tripan stain x10 
Fig. 8. MSCs morphology in one week 
culture. Tripan stain x40 
 
Cultivation optimal density was 106-107 cells/cm2 and after approximately 48h the 
BMSC population doubled. These results are similar to other reports (2, 4).  
MSCs morphology and culture capacities were maintained intact after repeated 
passages (fig. 9 and 10).  
 
  
Fig. 9. MSCs morphology before first 
passage. Tripan stain x10 
Fig. 10. MSCs morphology before 
second passage. Tripan stain x10 
 
Under the influence of osteoinductive factors, 20-25% of cells were positive to von 
Kossa stain after 15 days. 
The microscopic image of the collagen membranes (fig. 11) and collagen and 
hydroxyapatite matrixes (fig. 12) show a high cell density near and at the border of them, 




Fig. 11. Collagen membrane with 
chondroblasts. x20 
Fig. 12. Collagen and hydroxyapatite 
matrixes with osteoblasts. x20 
 
These observation confirm the data reported by Livingston et al. (6) that direct on 
scaffold differentiation allows a better dispersion of the cells in the carrier structure, thus 
skipping in vivo the period of time needed for scaffolds colonization and allowing for 





 The cellularity in humeral bone marrow had upper values in comparison with femoral 
condyle site and the MSCs had similar osteoblastic capacity.  
 The proper media preserve the viability and the optimal differentiation capacities bone 
marrow stromal cells.  
 Direct on scaffold differentiation allows an adequate dispersion of the cells in the carrier 
structure, thus skipping in vivo the period of time needed for matrix colonization. 
 In vitro cultivation and differentiation techniques of bone marrow stromal cells allow new 
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